Accuracy and safety of a new type of transfrontal lateral ventricular puncture in large hemispheric infarction
10.3760/cma.j.cn114656-20250102-00002
- VernacularTitle:大面积脑梗死困难侧脑室穿刺新方法及其精准性和安全性初探
- Author:
Xi ZHANG
1
;
Zhiyuan CHEN
;
Aidong ZHENG
;
Shu WANG
;
Hang WU
;
Yijun DENG
;
Jinbiao LUO
;
Shujie SUN
;
Hongtian ZHANG
;
Maogang CHEN
Author Information
1. 南通大学第六附属医院（盐城市第三人民医院）卒中中心，南通大学医学院，盐城 224055
- Keywords:
Cube orientation;
Lateral ventricle puncture;
Minimal invasive;
large hemispheric infarction;
External ventricular drainage;
Malignant middle cerebral arte
- From:
Chinese Journal of Emergency Medicine
2025;34(8):1113-1121
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the accuracy and safety profile of a novel cuboid orientation-guided frontal horn ventriculostomy technique in patients with large hemispheric infarction (LHI).Methods:It was conducted a retrospective cohort study of 48 consecutive LHI patients who underwent the innovative ventriculostomy procedure between time period. Primary outcomes included procedural accuracy (success rates, catheter positioning) and safety indicators (complication rates).Results:All the punctured ventricles were small or of normal size. The success rate of puncture was 100%, the success rate of one-time puncture was 87% (42/48), and the average number of puncture was 1.13 times per case. The ratio of well-positioned tube heads was 87.5% (42/48). The actual angle of the inward deviation of the puncture ranged from -2o to 5o, with an average of 0o±0.3o. The depth of puncture was 7.0-8.0 cm ( 7.3±0.3) cm. The incidence of bleeding around the puncture path was 1.3% (2/48 ) and no massive bleeding occurred. At the 6-month follow-up, one case (2.94%) among the 34 survivors had epilepsy.Conclusions:The cuboid orientation-guided frontal horn ventriculostomy technique demonstrates exceptional procedural accuracy and an excellent safety profile in LHI patients, with high first-pass success rates (87.5%) and minimal complications (4.2% minor hemorrhage). These findings support its clinical adoption for this patient population.
